Common misconceptions

Common mistake
Wrong: Glucose is reabsorbed in the PCT by simple diffusion following its concentration gradient.
Right: Glucose is reabsorbed in the PCT via secondary active transport (SGLT2 on the apical membrane), driven by the Na+ gradient established by basolateral Na+/K+ ATPase.
Glucose cannot move into PCT cells by simple diffusion because its luminal concentration is not reliably higher than intracellular concentration, and diffusion alone can't achieve near-complete reabsorption. Instead, SGLT2 on the apical membrane cotransports glucose with Na+, exploiting the low intracellular Na+ maintained by the basolateral Na+/K+-ATPase — this is secondary active transport, not passive. Glucose then exits the basolateral side via GLUT2 (facilitated diffusion), but the energy-requiring step is the Na+ gradient, not glucose movement per se.
Common mistake
Wrong: The thick ascending limb of the loop of Henle reabsorbs both solutes and water, concentrating the tubular fluid.
Right: The thick ascending limb is impermeable to water; it reabsorbs Na+/K+/2Cl- without water, diluting the tubular fluid and building the medullary osmotic gradient.
It's intuitive but wrong to think that a segment reabsorbing lots of solute would also concentrate the tubular fluid — that logic applies to the descending limb, not the ascending. The thick ascending limb has no aquaporins; water literally cannot follow the solutes being pumped out. This water-impermeability is what makes the countercurrent multiplier work: solutes accumulate in the medullary interstitium while the tubular fluid becomes progressively dilute as it ascends.
Common mistake
Wrong: Aldosterone acts primarily on the PCT to reabsorb the bulk of filtered sodium.
Right: Aldosterone acts on principal cells of the late DCT and collecting duct to fine-tune Na+ reabsorption and K+ secretion; bulk Na+ reabsorption occurs in the PCT independently of aldosterone.
The PCT reabsorbs roughly two-thirds of filtered Na+ without any aldosterone — it runs constitutively via Na+/H+ exchange and cotransporters. Aldosterone's job is fine-tuning, not bulk handling, and it does this specifically in the late DCT and collecting duct by upregulating ENaC (apical Na+ channels) and Na+/K+-ATPase in principal cells. Confusing these sites matters on the MCAT because it leads to wrong predictions about what happens to Na+ and K+ when aldosterone rises or falls.
Common mistake
Wrong: Loop diuretics (e.g., furosemide) work by blocking Na+ channels in the collecting duct.
Right: Loop diuretics inhibit the Na+/K+/2Cl- cotransporter (NKCC2) in the thick ascending limb, preventing medullary gradient formation and causing profound diuresis.
Collecting duct Na+ channels (ENaC) are the target of K-sparing diuretics like amiloride — not loop diuretics. Furosemide and other loop diuretics specifically inhibit NKCC2 in the thick ascending limb, which halts solute reabsorption there without affecting water (already impermeable). This collapses the medullary osmotic gradient, so even if ADH is present, the collecting duct has no gradient to drive water reabsorption — producing massive dilute urine and significant K+ and Mg2+ wasting.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Know the PCT's transport machinery: glucose and amino acids use Na+-coupled secondary active transport (SGLT2/other cotransporters), driven by the basolateral Na+/K+-ATPase — not passive diffusion.
  2. Understand the loop of Henle's countercurrent logic: the descending limb is permeable to water (not solutes), while the thick ascending limb pumps Na+/K+/2Cl- via NKCC2 and is completely impermeable to water, diluting tubular fluid and building the medullary gradient.
  3. Know where hormonal fine-tuning happens: aldosterone acts on principal cells of the late DCT and collecting duct to increase Na+ reabsorption and K+ secretion — not on the PCT, which handles bulk reabsorption constitutively.
  4. Apply nephron transport mechanisms to predict diuretic effects: loop diuretics block NKCC2 in the thick ascending limb (profound diuresis, hypokalemia); thiazides block NCC in the DCT; K-sparing diuretics (spironolactone, amiloride) target the collecting duct.

Can you avoid these mistakes?

A patient is given a drug that completely blocks SGLT2. Predict the effect on urine glucose levels and explain the transport mechanism that is being inhibited. Why does this drug not affect amino acid reabsorption?
Trace what happens to tubular fluid osmolarity as it travels from the descending limb to the thick ascending limb to the early DCT. At which point is the fluid most dilute, and why?
A patient with hyperaldosteronism (excess aldosterone) presents with hypertension and hypokalemia. Using your knowledge of aldosterone's site of action and its effects on principal cells, explain both findings mechanistically.
A novel diuretic blocks the Na+/Cl- cotransporter (NCC) in the DCT. Compare its expected potency (urine output) and effect on plasma K+ to that of furosemide. Which would cause more profound diuresis, and why?

Related topics

See how your Anki deck covers this topic.

Upload your deck for a free audit →